U.S. Metals and Mining Stock News

Polestar Automotive Holding UK (PSNY) has put out its FY 2025 first half numbers with revenue of US$1.4 billion and a basic EPS loss of US$16.92, as the company continues to run at a net loss. The business has seen revenue move from US$909.2 million in the first half of 2024 to US$1.1 billion in the second half of 2024 and then to US$1.4 billion in the first half of 2025. Over the same periods, basic EPS has shifted from a loss of US$7.73 to a loss of US$21.47 and now a loss of US$16.92,...

F.N.B (FNB) opened 2026 with Q1 revenue of US$431.8 million and basic EPS of US$0.38, setting the tone for how investors may read its latest income and profitability trends. Over the past year, the company has seen total revenue move from US$347.3 million in Q4 2024 to US$438.9 million in Q4 2025 and then to US$431.8 million in Q1 2026, while quarterly EPS shifted from US$0.30 to US$0.47 and now US$0.38. This gives a clearer view of how the top and bottom lines have been tracking into the new...

Open Text (NasdaqGS:OTEX) is expanding its European cloud footprint with availability on the AWS European Sovereign Cloud. The company announced a new partnership with S3NS, the Thales and Google Cloud joint venture, to offer trusted cloud solutions in France. The moves target European enterprises and public sector clients that prioritize data residency and regulatory compliance. Open Text focuses on information management and cloud based software that help organizations handle content,...

Quanta Services (NYSE:PWR) held its 2026 Investor Day, focusing on AI-related infrastructure, power grid modernization, and industrial reshoring opportunities. Management discussed a large addressable market through 2030 and shared long-term growth targets tied to data center power needs and grid upgrades. The company highlighted recent major contract wins as part of its updated long-term outlook in transformational infrastructure projects. Quanta Services, which builds and maintains...

Wondering if Visteon at around US$98.65 is offering real value or just recent excitement? This article walks through what the current share price might be implying about the business. The stock has shown sharp moves recently, with returns of 4.9% over 7 days, 16.8% over 30 days, 1.8% year to date and 38.6% over 1 year, set against weaker 3 year and 5 year returns of 32.3% and 15.6% declines. These mixed time frames suggest sentiment around Visteon has shifted at different points, which can...

State Street Q1 2026 earnings at a glance State Street (STT) has opened 2026 with a steady earnings profile, coming off Q4 2025 revenue of US$3.7b and basic EPS of US$2.46, backed by trailing twelve month revenue of US$13.9b and EPS of US$9.55. The company has seen revenue move from US$12.9b in the twelve months to Q4 2024 to US$13.9b in the latest twelve month period, while EPS over the same windows shifted from US$8.34 to US$9.55. This gives a clear sense of how the income statement is...

Badger Meter (BMI) has opened 2026 earnings season with Q1 results that sit against a trailing 12 month backdrop of US$916.7 million in revenue, basic EPS of US$4.82 and net income of US$141.6 million. The most recent reported quarter in 2025 showed revenue of US$220.7 million, basic EPS of US$1.14 and net income of US$33.6 million. Over the past six reported quarters, revenue has moved from US$205.2 million in Q4 2024 to a range between US$222.2 million and US$238.1 million through 2025,...

Alcoa Q1 2026 Earnings Snapshot Alcoa (AA) opened 2026 with Q1 revenue of US$3.2 billion and basic EPS of US$1.61, setting the tone for how the year is starting to shape up against prior performance. Over recent quarters, revenue has moved between US$3.0 billion and US$3.5 billion while quarterly EPS has ranged from roughly US$0.63 to US$2.08, giving investors a clear view of how top line and EPS have tracked together through different pricing and production conditions. With margins backing...

Bank First (BFC) opened 2026 with Q1 total revenue of US$63.7 million and basic EPS of US$1.78, alongside trailing twelve month revenue of US$193.7 million and EPS of US$7.18 that reflect five year earnings growth of 13.4% per year and 7.1% growth in the most recent year. Over the last few reported periods, revenue has moved from US$41.1 million in Q4 2024 to US$42.7 million in Q1 2025 and US$44.9 million in Q4 2025 before reaching US$63.7 million in Q1 2026, while quarterly EPS has ranged...

Cohen & Steers (CNS) has opened 2026 with Q1 revenue of US$145.6 million and basic EPS of US$0.82, supported by net income of US$42.4 million, setting a clear marker for how the year is starting to shape up. Over recent quarters the company has seen revenue move from US$134.5 million in Q1 2025 to US$143.8 million in Q4 2025 and now US$145.6 million in Q1 2026. Basic EPS has ranged from US$0.68 to US$0.90 across that period, giving investors a detailed view of how the top and bottom line are...

Independent Bank (INDB) opened 2026 with Q1 results that keep the focus firmly on the income statement, with recent quarters showing revenue stepping up from US$155.8 million in Q3 2024 to US$249.2 million in Q4 2025 and basic EPS moving from US$1.01 to US$1.52 over the same span, supported by trailing twelve month net income of US$205.1 million. Over that period, trailing revenue has shifted from US$653.5 million to US$792.1 million and trailing EPS has moved from US$4.52 to US$4.44, giving...

Definium Therapeutics is scheduled to present at the 25th Annual Needham Virtual Healthcare Conference. The conference appearance is expected to highlight the company’s latest developments for investors and healthcare industry participants. The event brings additional attention to NasdaqGS:DFTX at a time when the stock last closed at $22.68. For investors watching NasdaqGS:DFTX, this conference slot puts a fresh spotlight on Definium Therapeutics at a time when the share price sits at...

WaFd (WAFD) has posted Q2 2026 results with total revenue of US$193.4 million and basic EPS of US$0.82, setting the tone for another earnings season where profitability is front and center. The bank has seen quarterly revenue move from US$177.0 million in Q2 2025 to US$185.3 million in Q4 2025 and then to US$193.4 million in Q2 2026, while basic EPS over the same period has gone from US$0.65 to US$0.73 and now US$0.82, giving investors a clear view of how earnings are tracking alongside the...

Insteel Industries Q2 2026 earnings snapshot Insteel Industries (IIIN) has put fresh numbers on the table for Q2 2026, reporting revenue of US$172.7 million and basic EPS of US$0.27 on net income of US$5.2 million, with the trailing twelve months showing EPS of US$2.18 on net income of US$42.5 million. Over the past six quarters, revenue has moved within a band from US$129.7 million in Q1 2025 to US$179.9 million in Q3 2025, while quarterly EPS has ranged from US$0.06 to US$0.78, providing a...

PrimeEnergy Resources (PNRG) has wrapped up FY 2025 with fourth quarter revenue of US$51.6 million and basic EPS of US$2.07, alongside trailing 12 month revenue of US$187.4 million and EPS of US$15.85. Over recent periods the company has seen quarterly revenue move from US$60.4 million in Q4 2024 to US$51.6 million in Q4 2025, while basic EPS shifted from US$1.33 to US$2.07 across the same quarters, with trailing net income at US$26.3 million. With net profit margin sitting at 14% over the...

Earlier this year, Calumet reported quarterly results showing a 9.4% year-on-year increase in revenue but falling short of analysts’ revenue and EBITDA expectations. The combination of revenue growth and an earnings miss highlighted investors’ focus on Calumet’s longer-term transformation story rather than short-term forecast deviations. We’ll now examine how this mix of year-on-year revenue growth and weaker-than-expected EBITDA shapes Calumet’s broader investment narrative. The best AI...

Why ANI Pharmaceuticals Is On Investors’ Radar Today ANI Pharmaceuticals (ANIP) is drawing attention after recent share price moves, with the stock up about 5% over the past month but showing a roughly 8% decline over the past 3 months. See our latest analysis for ANI Pharmaceuticals. Looking past the recent 5.1% 1 month share price return, ANI Pharmaceuticals’ share price has softened over the last quarter while the 1 year total shareholder return of 12.8% and 5 year total shareholder return...

Wondering if TG Therapeutics at around US$34.30 is pricing in too much hope or not enough future potential? This article breaks down what that current tag may actually reflect. The stock has been volatile, with a 1% decline over the last 7 days, an 8.9% gain over 30 days, a 17.1% gain year to date, but a 10.5% decline over the past year and a 16.5% decline over 5 years, all against a 60.4% gain over 3 years. Recent news coverage around TG Therapeutics has focused on its position within the...

If you are wondering whether BJ's Wholesale Club Holdings is priced attractively or already reflects its strengths, it helps to start with how the current share price lines up against different valuation checks. The stock closed at US$92.24, with returns of a 1.5% decline over 7 days, a 4.4% decline over 30 days, a small 0.3% gain year to date, and a 22.1% decline over the last year, following a 19.0% return over 3 years and 112.9% over 5 years. Recent coverage has focused on BJ's position...

Leadership change puts BioCryst’s R&D focus in the spotlight BioCryst Pharmaceuticals (BCRX) recently named Sandeep M. Menon as Chief Research and Development Officer, putting fresh attention on how new leadership could shape the company’s rare disease pipeline and longer term growth plans. See our latest analysis for BioCryst Pharmaceuticals. The appointment of Dr. Menon comes at a time when BioCryst’s share price has a 90 day share price return of 42.9% and a 1 year total shareholder return...

CRA International (CRAI) is back in focus after recent share price swings. The stock has been roughly flat over the past year but has shown a negative move over the past 3 months. See our latest analysis for CRA International. Recent trading tells a mixed story, with a 4.1% 30 day share price return set against a 23.1% decline over 90 days, while the 5 year total shareholder return of 126.2% reflects much stronger long term performance. If CRA International’s recent swings have you thinking...

Spire (NYSE:SR) agreed to sell its natural gas storage assets in Wyoming and Oklahoma to I Squared Capital. The transaction shifts Spire's portfolio toward regulated natural gas utilities and supports funding for its recent Nashville acquisition. The move reflects a material change in business mix and risk profile that has not yet been widely discussed. Spire is primarily a regulated natural gas utility, and this agreement to sell Wyoming and Oklahoma storage assets tightens that focus. By...

Over the last 7 days, the United States market has experienced a significant decline of 29%, contributing to an overall drop of 82% over the past year, though earnings are forecast to grow by 16% annually. In such volatile conditions, identifying stocks that are undervalued relative to their intrinsic value can present opportunities for investors seeking potential long-term gains.

If you are wondering whether Gap's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current market price might be implying about the company. Gap's stock has seen a 40.3% return over the last year and 209.3% over the last 3 years, while the most recent 7 day return of a 1.1% decline sits against a 9.4% gain over the last 30 days and a 3.5% return year to date. Recent headlines around Gap have focused on...